Company Research Report: SecondWave Systems, Inc.

Company Overview

• Name: SecondWave Systems, Inc.

• Mission: To improve lives with an innovative method to treat illness. SecondWave Systems aims to provide cost-effective, personalized interventions for chronic conditions to avoid the invasiveness and side effects associated with many traditional treatment approaches.

• Founded: No information is available.

• Founder(s): No information is available.

• Key People:

• Anuj Bhardwaj, Chief Executive Officer: Anuj has vast experience in ultrasound, bioelectric medicine, and advanced technology. He has a background in transitioning new technologies into high-impact applications.

• Hubert H. Lim, PhD, Chief Scientific Officer: Hubert is an Endowed Professor in the Medical School and College of Science & Engineering and is deeply involved in medical devices and neuromodulation technologies.

• Jeff Heyman, Chief Operating Officer: Jeff brings nearly 20 years of experience in medical device product development, having worked with medical technology leaders.

• Headquarters: No information is available.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Developing a noninvasive, wearable ultrasound stimulation platform that provides alternatives to traditional treatments with fewer side effects.

Products

• Product Offering:

• SecondWave Systems is developing a noninvasive, wearable ultrasound stimulation platform.

• High-Level Description:

• The platform uses noninvasive, low-intensity focused ultrasound (LiFU) technology to modulate nerves, cells, and organs.

• Key Features:

• Noninvasive: The platform utilizes low-intensity ultrasound to alter physiological states without creating incisions, serving as a substitute for medication-based therapies.

• Wearable: Designed with a miniaturized form factor for easy in-home use, reducing dependency on clinical visits.

• Broad Clinical Applications: It can modulate or suppress neural and cellular pathways to potentially treat conditions like inflammation and pain.

• Intelligent: The device includes proprietary sensing and imaging for adaptive, personalized therapy, offering a cost-effective, scalable solution.

Recent Developments

• Clinical Study and Therapy Development:

• May 1, 2024: The company demonstrated a reduction in disease activity in a clinical study evaluating its novel ultrasound-based anti-inflammatory therapy for rheumatoid arthritis.

• March 27, 2024: Professor Paul Peter Tak joined as a new advisory board member. The company also secured $3 million in additional financing to accelerate its development of the novel anti-inflammatory therapy.

• Major Collaborations and Funding:

• April 20, 2021: SecondWave Systems secured over $7 million from the Department of Defense to accelerate the development and clinical study of its novel low-intensity focused ultrasound technology for anti-inflammatory therapy.

• Research and Presentations:

• April 6, 2021: CEO Anuj Bhardwaj participated in an entrepreneur panel during the Neurotech Reports 2021 Bioelectronic Medicine Forum.

• July 20, 2020: CSO Hubert Lim gave a keynote address at Ultrasonics 2020 on new research into low-intensity focused ultrasound for treating debilitating diseases.

• New Partnerships: No new partnerships beyond the advisory board update mentioned.